Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells

作者：Cocco Emiliano; Deng Yang; Shapiro Erik M; Bortolomai Ileana; Lopez Salvatore; Lin Ken; Bellone Stefania; Cui Jiajia; Menderes Gulden; Black Jonathan D; Schwab Carlton L; Bonazzoli Elena; Yang Fan; Predolini Federica; Zammataro Luca; Altwerger Gary; de Haydu Christopher; Clark Mitchell; Alvarenga Julio; Ratner Elena; Azodi Masoud; Silasi Dan Arin; Schwartz Peter E; Litkouhi Babak; Saltzman W Mark; Santin Alessandro D^*

来源：Molecular Cancer Therapeutics, 2017, 16(2): 323-333.

DOI：10.1158/1535-7163.MCT-16-0501

Ovarian cancer is the most lethal gynecologic cancer. Claudin-3 and -4, the receptors for Clostridium perfringens enterotoxin (CPE), are overexpressed in more than 70% of these tumors. Here, we synthesized and characterized poly (lactic-co-glycolic-acid) (PLGA) nanoparticles (NPs) modified with the carboxy-terminal-binding domain of CPE (c-CPE-NP) for the delivery of suicide gene therapy to chemotherapyresistant ovarian cancer cells. As a therapeutic payload, we generated a plasmid encoding for the diphtheria toxin subunit-A (DT-A) under the transcriptional control of the p16 promoter, a gene highly differentially expressed in ovarian cancer cells. Flow cytometry and immunofluorescence demonstrated that c-CPE-NPs encapsulating the cytomegalovirus (CMV) GFP plasmid (CMV GFP c-CPE-NP) were significantly more efficient than control NPs modified with a scrambled peptide (CMV GFP scr-NP) in transfecting primary chemother-apy-resistant ovarian tumor cell lines in vitro (P similar to 0.03). Importantly, c-CPE-NPs encapsulating the p16 DT-A vector (p16 DT-A c-CPE-NP) were significantly more effective than control p16 DT-A scr-NP in inducing ovarian cancer cell death in vitro (% cytotoxicity: mean + SD = 32.9 +/- 0.15 and 7.45 +/- 7.93, respectively, P = 0.03). In vivo biodistribution studies demonstrated efficient transfection of tumor cells within 12 hours after intraperitoneal injection of CMV GFP c-CPE-NP in mice harboring chemotherapy-resistant ovarian cancer xenografts. Finally, multiple intraperitoneal injections of p16 DT-A c-CPE-NP resulted in a significant inhibition of tumor growth compared with control NP in chemotherapy-resistant tumorbearing mice (P = 0.041). p16 DT-A c-CPE-NP may represent a novel dual-targeting therapeutic approach for the selective delivery of gene therapy to chemotherapy-resistant ovarian cancer cells.

• 出版日期2017-2